scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028927971 |
P356 | DOI | 10.1007/S00223-013-9764-0 |
P698 | PubMed publication ID | 23912951 |
P5875 | ResearchGate publication ID | 255177497 |
P2093 | author name string | Nicole J Horwood | |
Sarah E Wythe | |||
Vicky Nicolaidou | |||
P2860 | cites work | Regulatory T cells protect from local and systemic bone destruction in arthritis. | Q53294686 |
Ovariectomy-induced bone loss occurs independently of B cells. | Q53510692 | ||
T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. | Q53597060 | ||
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. | Q54041247 | ||
IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. | Q54042043 | ||
IL-3 inhibits human osteoclastogenesis and bone resorption through downregulation of c-Fms and diverts the cells to dendritic cell lineage. | Q54661767 | ||
Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype. | Q54775046 | ||
β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice | Q57116531 | ||
Immune Interactions with CD4+ T Cells Promote the Development of Functional Osteoclasts from Murine CD11c+ Dendritic Cells | Q57184758 | ||
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 | Q57675161 | ||
Oncostatin M Stimulates c-Fos to Bind a Transcriptionally Responsive AP-1 Element within the Tissue Inhibitor of Metalloproteinase-1 Promoter | Q58211802 | ||
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL | Q24338171 | ||
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells | Q24627585 | ||
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice | Q24642117 | ||
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling | Q24647357 | ||
Exploring the full spectrum of macrophage activation | Q24653754 | ||
New ways to turn on NKT cells | Q27693911 | ||
Bone resorption by osteoclasts | Q28145169 | ||
Skeletal remodeling in health and disease | Q28235713 | ||
Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents | Q28473076 | ||
Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes | Q28576957 | ||
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
Alternative activation of macrophages: mechanism and functions | Q29614350 | ||
Innate or adaptive immunity? The example of natural killer cells | Q29615106 | ||
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery | Q30538833 | ||
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile | Q33532608 | ||
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss | Q33610901 | ||
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. | Q33916614 | ||
Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo | Q33950241 | ||
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis | Q34059280 | ||
Long-term treatment of osteopetrosis with recombinant human interferon gamma | Q34310828 | ||
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions | Q34323476 | ||
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation | Q34339627 | ||
Imaging of axial spondyloarthritis including ankylosing spondylitis | Q37845583 | ||
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives | Q37903458 | ||
Immune regulatory function of B cells. | Q37973774 | ||
Osteoblast and osteoclast crosstalks: from OAF to Ephrin | Q37978923 | ||
Tec family kinases in inflammation and disease | Q37997073 | ||
New developments in osteoimmunology | Q38052462 | ||
B-cell targeted therapeutics in clinical development | Q38097162 | ||
Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells | Q38506162 | ||
Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function | Q38525468 | ||
Prostaglandin E2 receptor EP4-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation | Q39305262 | ||
Developmental abnormalities in mice transgenic for bovine oncostatin M. | Q40016116 | ||
Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines | Q40241909 | ||
A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation | Q40498732 | ||
Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes | Q40626937 | ||
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome | Q40663505 | ||
Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. | Q40756953 | ||
B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta | Q40875461 | ||
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. | Q41782419 | ||
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages | Q42253863 | ||
The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells | Q42629540 | ||
Activated invariant NKT cells regulate osteoclast development and function | Q42688148 | ||
Monokines produced by macrophages stimulate the growth of osteoblasts | Q43947297 | ||
On the origin of the osteoclast: the cell surface phenotype of rodent osteoclasts | Q44244623 | ||
Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo | Q46277067 | ||
Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis | Q46287428 | ||
Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling | Q46291802 | ||
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model | Q46294640 | ||
Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells | Q46295011 | ||
Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury model. | Q46369480 | ||
IL-10-producing macrophages preferentially clear early apoptotic cells | Q46960586 | ||
Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice. | Q47397479 | ||
Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos. | Q50925640 | ||
Natural killer cell memory. | Q51000689 | ||
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. | Q51506098 | ||
Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. | Q34412527 | ||
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand | Q34490668 | ||
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders | Q34797835 | ||
Risk of vertebral fracture in women with rheumatoid arthritis | Q35187252 | ||
IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation | Q35219971 | ||
Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism | Q35367510 | ||
Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis | Q35534758 | ||
CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin | Q35597152 | ||
Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand | Q35748007 | ||
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo | Q35804512 | ||
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH | Q35849800 | ||
T cells and post menopausal osteoporosis in murine models | Q35868950 | ||
Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. | Q35918333 | ||
Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation | Q36002625 | ||
Osteoclast-derived activity in the coupling of bone formation to resorption. | Q36032429 | ||
Inflammatory bone destruction and osteoimmunology | Q36168550 | ||
Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name... | Q36388212 | ||
Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function | Q36497982 | ||
Osteoclasts, rheumatoid arthritis, and osteoimmunology | Q36501073 | ||
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide | Q36550855 | ||
The role of mast cells in osteoporosis | Q36556168 | ||
IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. | Q36806362 | ||
Dendritic cell-mediated in vivo bone resorption. | Q36838568 | ||
The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell | Q36979047 | ||
Novel biphasic role for lymphocytes revealed during resolving inflammation | Q37014326 | ||
Identification of cell cycle-arrested quiescent osteoclast precursors in vivo | Q37124343 | ||
COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing | Q37172205 | ||
Colony-stimulating factors in inflammation and autoimmunity. | Q37190439 | ||
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha | Q37271202 | ||
Osteal macrophages: a new twist on coupling during bone dynamics | Q37286721 | ||
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. | Q37329573 | ||
Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption | Q37381554 | ||
Molecular mechanisms in coupling of bone formation to resorption. | Q37385000 | ||
GP130 cytokines and bone remodelling in health and disease | Q37783364 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell function | Q95674809 |
P304 | page(s) | 98-111 | |
P577 | publication date | 2013-08-03 | |
P1433 | published in | Calcified Tissue International | Q5018771 |
P1476 | title | Cells of the immune system orchestrate changes in bone cell function | |
P478 | volume | 94 |
Q38634916 | A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts |
Q39714405 | Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT. |
Q37506724 | Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit |
Q39187466 | Defective Bone Repair in C57Bl6 Mice With Acute Systemic Inflammation |
Q36174720 | Estrogen accelerates the resolution of inflammation in macrophagic cells |
Q47100950 | Immunology of Gut-Bone Signaling. |
Q41482320 | Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro. |
Q45323711 | Osteoblasts Are Rapidly Ablated by Virus-Induced Systemic Inflammation following Lymphocytic Choriomeningitis Virus or Pneumonia Virus of Mice Infection in Mice |
Q36267598 | Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis |
Q42122931 | Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis |
Search more.